UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003825
Receipt number R000004609
Scientific Title Nasal provocation test in pediatric patients with perennial allergic rhinitis
Date of disclosure of the study information 2010/06/25
Last modified on 2010/09/05 08:48:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Nasal provocation test in pediatric patients with perennial allergic rhinitis

Acronym

Nasal provocation test in pediatric patients with perennial allergic rhinitis

Scientific Title

Nasal provocation test in pediatric patients with perennial allergic rhinitis

Scientific Title:Acronym

Nasal provocation test in pediatric patients with perennial allergic rhinitis

Region

Japan


Condition

Condition

perennial allergic rhinitis

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the validity of the nasal provocation test in the clinical setting in pediatric patients with perennial allergic rhinitis.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Subjective and objective symptoms

Key secondary outcomes

results of rhinomanometry


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Disc for nasal provocation

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

10 years-old <=

Age-upper limit

14 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Patients with perennial allergic rhinitis who have at least a 2-year history of allergic symptoms.
2. Patients who have had blood test within 2 years showing positive UniCAP scores for housedust/mite.
3.Patients and their parents who given informed consent

Key exclusion criteria

1. Patients with acute rhinits, simple rhinitis, atgrophic rhinitis, and sinusitis.
2. Patients with nasal obstruction attributable to nasal polyps or nasal deformity.
3. Patients who have undergone immunotherapy with housedust/mite.
4. Patients who have undergone nasal operation such as turbinectomy, choncotomy, and laser surgery.
5. Patients who show complete nasal obstruction after induced a control disc.
6. Patients with uncontrolled asthma.
7. Patients with severe drug allergy.
8. Patients who used anti-allergic or anti-histamine drugs within one week or steroid within one month prior to the start of this study.
9. Patients with allergic diseases except allergic rhinitis such as atopic dermatitis or food allergy which might not show exacerbation after nasal provocation test.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazuhiro Hashiguchi

Organization

Kitasato University Kitsato institute Hospital

Division name

Otolaryngology

Zip code


Address

5-9-1 Shirokane, Minato-ku, Tokyo 108-8642, Japan

TEL

03-3444-6161

Email



Public contact

Name of contact person

1st name
Middle name
Last name Kiyochika Suematsu

Organization

Samoncho Clinc

Division name

Administration department

Zip code


Address

20 Samontyo, Shinjyuku-ku, Tokyo 160-0017, Japan

TEL

03-5366-3641

Homepage URL


Email



Sponsor or person

Institute

Samoncho Clinic

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

左門町クリニック


Other administrative information

Date of disclosure of the study information

2010 Year 06 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 05 Month 26 Day

Date of IRB


Anticipated trial start date

2010 Year 06 Month 01 Day

Last follow-up date

2010 Year 06 Month 01 Day

Date of closure to data entry

2010 Year 07 Month 01 Day

Date trial data considered complete

2010 Year 10 Month 01 Day

Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 06 Month 25 Day

Last modified on

2010 Year 09 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004609


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name